Pfizer (PFE) recently reported a revenue decline tied to weaker COVID product sales and a US$4.4b impairment charge, while ...
(Reuters) -U.S. drugmaker Pfizer could work its connections within President Donald Trump's administration to try to thwart Novo Nordisk's surprise rival bid to acquire U.S. obesity biotech firm ...
StockStory.org on MSN
Q4 earnings highs and lows: Pfizer (NYSE:PFE) vs the rest of the branded pharmaceuticals stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Pfizer (PFE) fell ~5% on Tuesday as Wall Street analysts assessed mid-stage data the company posted for its obesity therapy PF-08653944 ahead of its consensus-beating Q4 2025 results, which indicated ...
LONDON (Reuters) -Novo Nordisk's late bid to hijack Pfizer's takeover of U.S. obesity biotech Metsera marks an aggressive shift from the Danish drugmaker as it seeks to regain ground in the ...
Final analysis: Pfizer's COVID-19 vaccine 95% effective, company to seek authorization within 'days'
A final analysis of a COVID-19 vaccine candidate produced by Pfizer and BioNTech shows that the drug is 95% effective in preventing the coronavirus, and the companies say they hope to apply for ...
This podcast comes from the DPHARM 2025 meeting. Pfizer details how they jointly co-designed and implemented an EDC/CDMS platform that’s fit for purpose. This session focuses on: Engaging all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results